Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870483 | PMC |
| http://dx.doi.org/10.3389/fphar.2020.625295 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
Front Pharmacol
January 2021
Department of Anesthesiology, Perioperative and Pain Medicine, Son Espases University Hospital, Palma de Mallorca, Spain.
Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
Front Pharmacol
October 2020
Dipartimento di Scienze per la Qualità della Vita, Università degli Studi di Bologna, Rimini, Italy.
COVID-19 pandemic is posing an unprecedented sanitary threat: antiviral and host-directed medications to treat the disease are urgently needed. A great effort has been paid to find drugs and treatments for hospitalized, severely ill patients. However, medications used for the domiciliary management of early symptoms, notwithstanding their importance, have not been and are not presently regarded with the same attention and seriousness.
View Article and Find Full Text PDFmiRNA-324, a potential therapeutic target for paracetamol-induced liver injury.
Stem Cell Investig
October 2016
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
Paracetamol-induced endocrine disruption in human fetal testes.
Nat Rev Endocrinol
August 2015
Irset-INSERM UMR 1085, Campus de Beaulieu, Avenue du Général Leclerc, 35042 Rennes Cedex, France.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!